Lee Eunseuk, Ozigbo Adaobi Amelia, Varon Joseph, Halma Mathew, Laezzo Madison, Ang Song Peng, Iglesias Jose
Department of Internal Medicine, Rutgers Health/Community Medical Center, Toms River, NJ 08755, USA.
College of Integrated Health Sciences, University at Albany SUNY, Albany, NY 12222, USA.
Biomolecules. 2025 Sep 18;15(9):1339. doi: 10.3390/biom15091339.
Post-acute sequelae of SARS-CoV-2 infection (long COVID) present with persistent fatigue, cognitive impairment, and autonomic and multisystem dysfunctions that often go unnoticed by standard diagnostic tests. Increasing evidence suggests that mitochondrial dysfunction and oxidative stress are central drivers of these post-viral sequelae. Viral infections, particularly SARS-CoV-2, disrupt mitochondrial bioenergetics by altering membrane integrity, increasing mitochondrial reactive oxygen species (mtROS), and impairing mitophagy, leading to sustained immune activation and metabolic imbalance. This review synthesizes an understanding of how mitochondrial redox signaling and impaired clearance of damaged mitochondria contribute to chronic inflammation and multisystem organ symptoms in both long COVID and post-vaccine injury. We discuss translational biomarkers and non-invasive techniques, exploring therapeutic strategies that include pharmacological, non-pharmacological, and nutritional approaches, as well as imaging modalities aimed at assessing and restoring mitochondrial health. Recognizing long COVID as a mitochondrial disorder that stems from redox imbalance will open new options for personalized treatment and management guided by biomarkers. Future clinical trials are essential to validate these approaches and translate mitochondrial resuscitation into effective care for patients suffering from long COVID and related post-viral syndromes.
新型冠状病毒感染的急性后遗症(长新冠)表现为持续疲劳、认知障碍以及自主神经和多系统功能障碍,而标准诊断测试往往无法察觉这些症状。越来越多的证据表明,线粒体功能障碍和氧化应激是这些病毒后后遗症的主要驱动因素。病毒感染,尤其是新型冠状病毒,通过改变膜完整性、增加线粒体活性氧(mtROS)以及损害线粒体自噬来破坏线粒体生物能量学,导致持续的免疫激活和代谢失衡。本综述综合阐述了线粒体氧化还原信号传导和受损线粒体清除功能障碍如何导致长新冠和疫苗接种后损伤中的慢性炎症和多系统器官症状。我们讨论了转化生物标志物和非侵入性技术,探索了包括药理学、非药理学和营养方法在内的治疗策略,以及旨在评估和恢复线粒体健康的成像方式。将长新冠视为一种源于氧化还原失衡的线粒体疾病,将为基于生物标志物的个性化治疗和管理开辟新的选择。未来的临床试验对于验证这些方法并将线粒体复苏转化为对长新冠及相关病毒后综合征患者的有效治疗至关重要。